Viruses constantly mutate as they spread, and SARS-CoV-2 is no exception. New variants have emerged globally, some of which spread more easily or may evade immune protections. While vaccination and continued safety measures are critical to slowing transmission, an increase in cases from a more transmissible variant could still overwhelm hospitals. Ongoing genomic surveillance of variants and strict adherence to public health guidelines remain essential to reduce the virus's opportunities to evolve.
Prevention of infection in dental clinic in COVID-19Prachi Jha
PREVENTION OF INFECTION IN DENTAL CLINIC DURING COVID 19 PANDEMIC IN ACCORDANCE WITH GUIDELINES ISSUED BY MOHFW, CDC, IDA, DCI AND IT'S APPLICATION WITH AN ENDODNOTISTS'S POINT OF VIEW
Prevention of infection in dental clinic in COVID-19Prachi Jha
PREVENTION OF INFECTION IN DENTAL CLINIC DURING COVID 19 PANDEMIC IN ACCORDANCE WITH GUIDELINES ISSUED BY MOHFW, CDC, IDA, DCI AND IT'S APPLICATION WITH AN ENDODNOTISTS'S POINT OF VIEW
Care start access bio antigen test covid 19 biotechh commerceHafsaWadood1
The care start covid-19 antigen test is a lateral flow immuno-chromatographic assay, for the qualitative detect of the SARS coronavirus nucleo-capsid protein (major antigen). It is a rapid, easy, diagnostic test for the qualitative detection of Covid-19 antigen. This device is intended for use at Point of Care (POC) testing services.
Prevention of Surgical Site Infection- SSI [compatibility mode]drnahla
Infection Control Guidelines for Prevention of Surgical Site Infection- SSI
Dr. NAHLA ABDEL KADERوMD, PhD.
INFECTION CONTROL CONSULTANT, MOH
INFECTION CONTROL CBAHI SURVEYOR
Infection Control Director, KKH.
buy carestart covid-19 Antigen test by bio Access Inc, EUA Approvel Letter by...HK HuZef
buy carestart covid-19 Antigen test by bio Access Inc, EUA Approvel Letter by US-FDA for USA
Due to the highly contagious nature and global
health crises, SARS-CoV-2 has been designated
as a pandemic by the World Health Organization
(WHO) and continues to have devastating
impacts on healthcare systems and the world
economy including the U.S.
To effectively end the SARS-CoV-2 pandemic,
systematic screening and detection of clinical
COVID-19 cases is critical. An effective screening
regimen in a workplace, campus or other
community setting can be established using
the quick results provided by antigen tests.
As an intended point-of-care (POC) designated
test with a 10 min processing time, CareStart™
COVID-19 Antigen Test allows effective screening
of COVID-19 infection on a large scale.
Features
( Lateral flow assay
( No equipment required
( Rapid results within 10 minutes
( Minimally invasive specimen collection
(nasopharyngeal)
( Intended at POC setting by
medical professionals
Clinical Features
( Detect SARS-CoV-2 nucleocapsid
protein antigen with ultra high
performance
( Identify acute infection with high
sensitivity and 100% specificity
Test Principles
The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal and nasal swab specimens directly collected from individuals who are suspected of COVID-19 by their healthcare providers.
Hospital Acquired Infections/Health care associated infections/Nosocomial infection .
More useful for MBBS ,PG (MD/MS) Students to get a brief idea about HAI.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Care start access bio antigen test covid 19 biotechh commerceHafsaWadood1
The care start covid-19 antigen test is a lateral flow immuno-chromatographic assay, for the qualitative detect of the SARS coronavirus nucleo-capsid protein (major antigen). It is a rapid, easy, diagnostic test for the qualitative detection of Covid-19 antigen. This device is intended for use at Point of Care (POC) testing services.
Prevention of Surgical Site Infection- SSI [compatibility mode]drnahla
Infection Control Guidelines for Prevention of Surgical Site Infection- SSI
Dr. NAHLA ABDEL KADERوMD, PhD.
INFECTION CONTROL CONSULTANT, MOH
INFECTION CONTROL CBAHI SURVEYOR
Infection Control Director, KKH.
buy carestart covid-19 Antigen test by bio Access Inc, EUA Approvel Letter by...HK HuZef
buy carestart covid-19 Antigen test by bio Access Inc, EUA Approvel Letter by US-FDA for USA
Due to the highly contagious nature and global
health crises, SARS-CoV-2 has been designated
as a pandemic by the World Health Organization
(WHO) and continues to have devastating
impacts on healthcare systems and the world
economy including the U.S.
To effectively end the SARS-CoV-2 pandemic,
systematic screening and detection of clinical
COVID-19 cases is critical. An effective screening
regimen in a workplace, campus or other
community setting can be established using
the quick results provided by antigen tests.
As an intended point-of-care (POC) designated
test with a 10 min processing time, CareStart™
COVID-19 Antigen Test allows effective screening
of COVID-19 infection on a large scale.
Features
( Lateral flow assay
( No equipment required
( Rapid results within 10 minutes
( Minimally invasive specimen collection
(nasopharyngeal)
( Intended at POC setting by
medical professionals
Clinical Features
( Detect SARS-CoV-2 nucleocapsid
protein antigen with ultra high
performance
( Identify acute infection with high
sensitivity and 100% specificity
Test Principles
The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal and nasal swab specimens directly collected from individuals who are suspected of COVID-19 by their healthcare providers.
Hospital Acquired Infections/Health care associated infections/Nosocomial infection .
More useful for MBBS ,PG (MD/MS) Students to get a brief idea about HAI.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
MD Inservice
1.
2. One thing we know for sure about SARS-CoV-2, the virus that causes
COVID-19, is that it is changing constantly. Since the beginning of the
pandemic, we’ve seen a number of prominent variants, including Alpha,
Viruses constantly change through mutation and sometimes these mutations
the virus.
Although new variants are an expected part of the evolution of viruses,
surfaces is essential in ensuring we—in the U.S. and globally—are prepared.
new variant is more aggressive, highly transmissible, vaccine-resistant, able
disease—or all of the above, compared with the original strain of the virus.
Some variants spread more easily and quickly than other variants, which may
COVID-19. Even if a variant causes less severe disease in general, an
of cases could cause an increase in hospitalizations, put more strain on
potentially lead to more deaths.
3. STRICT
MEASURES
CRITICAL TO
SLOW
SPREAD OF
THE
DISEASE
Mask mandates
Social Distance
Curfews
Limiting number of people who
gather indoors
Closure of open venues
Stay home if sick
Quarantine/Isolate if COVID-19
Vaccine administrations
Herd immunity
Hand washing
4. COVID-19 is spread in 3 ways according
to the experts:
1.By breathing in air when close to an
infected person who is exhaling small
droplets and particles that contain the
virus
2.Having these droplets and particles land
on the eyes, nose, or mouth
3.Or touching the eyes, nose, and mouth
with hands that have the virus on them.
The more closely you interact with others and
the longer that interaction, the higher the risk
of COVID-19 spread, and indoor spaces are
6. Appropriate Use of PPE
• Hand Hygiene before putting on
PPE and after removal of PPE
• Donning: gown, KN95 or mask,
face shield/goggles, gloves,
bouffant cap as indicated
• Doffing: gloves, gown, face
shield/goggles, mask or KN95
• Optimizing PPE usage
Daily inventory
Limited reuse of KN95s if shortage
Maintain allocations
12. Cleaning and Disinfecting:
A 2 Step Process
• Cleaners or detergents are products that remove soil, dirt,
dust, organic matter, and germs (like bacteria, viruses, and
fungi). Cleaning is necessary to remove dirt that can prevent
disinfectants from working.
• Disinfectants are chemical products that are used to kill germs
in healthcare settings. Disinfecting kills germs on surfaces. By
killing germs on a surface after cleaning, it can further lower
the risk of spreading infection. The disinfectant’s label should
have a list of germs that the product can kill. Use an EPA-
approved disinfectant against COVID-19.
• Cleaning and Disinfection Technique:
√ Progress from cleanest to dirtiest areas, from higher to lower levels and
done systematically
√ Use fresh cloth at start of each cleaning session
√ Discard cloth if no longer saturated with solution
13. REFERENCE GUIDE FOR CLEANING AT THE STONE CENTER
ALL EPA
APPROVED TO
FIGHT COVID-19
FOLLOW
CONTACT TIMES
TO BE
EFFECTIVE
CAVI WIPES**
Contact time:
2 minutes
SARS-CoV-2 (COVID-
19) Contact time: 2
minutes
CAVI WIPES**
Contact time:
2 minutes
SARS-CoV-2 (COVID-19)
Contact time:
2 minutes
SUPER SANI
CLOTH
Contact time:
2 minutes
SARS-CoV-2
(COVID-19)
Contact time:
1 minute
GERMICIDIAL
BLEACH WIPES:
Contact time:
3 minutes
SARS-CoV-2
(COVID-19) Contact
time:
30 seconds
70% ALCOHOL
Contact time:
30 Seconds
SARS-CoV-2
(COVID-19)
Contact time:
5 minutes
SANI CLOTH AF
Contact time:
3 minutes
SARS-CoV-2
(COVID-19)
Contact time:
3 minutes
PENTA WIPES
Contact time:
2 minutes
SARS-CoV-2
(COVID-19)
Contact time:
TROPHON
COMPANION
CLEANING WIPES
Contact time: 4
minutes ↓
SARS-CoV-2
(COVID-19)
Contact time:
4 minutes
CAVICIDE
SPRAY on
Lint Free
Cloths
Contact time:
2 minutes
SARS-CoV-2
(COVID-19)
Contact
time:
2 minutes
Medication area Cysto table/pads
Accu Check
Machine
B/P Cuff
ESWL table
therapy head
CLEANING↓
Trophon Drying
Wipe
↓
Neptune
Rover
Stretchers Laser Litho
(Use BP shield –
protect patient
from BP cuff
touching skin – no
patient contact)
Cardiac monitor
UroNav Sensor
Wire
Ultrasound
Transducer
Trophon EPR
High Level
Disinfection
Bedside trays
GLL pedals Anesthesia
circuit holder
DISINFECTING
With
CAVIWIPE↓
Prostate probe
↓
IV Poles
ESWL Table /Pads
^Defibrillator
on Crash Cart &
Accessories
Monitors
(cardiac, pulse
O2,CO2)
Ultrasound
Transducer
Trophon Drying
Wipe
Folding Chairs Anesthesia Cart Laser glasses
B/P cords Anesth. Machine
EKG monitors Skytron 3100 Table
Bedside O2, suction Ultrasound/UroNav
Touch Surfaces
Phones, doorknobs,
light switches, etc.
^Defibrillator on Crash
Cart & Accessories
**Contact time: 3 minutes to kill TB; Pseudomonas Aeruginosa, Salmonella Enterica, Staph Aureus; T. mentagrophytes 10/2018; Revised 5/2020; Revised 6/2020; Revised 10/2021
^CaviWipes or Sani Cloths can be used on Defibrillator on Crash Cart with accessories as per IFU
14. Cleaning
and
Disinfecting
High Touch
Surfaces
High touch surfaces include:
• Door handles, refrigerator handle
• Horizontal surfaces: desks, counters in
lounge, counters in RR, table in staff
lounge, etc.
• Phones/Cellphones/keyboards
• Pens
• Screening thermometers
• Chairs in lobby/lounge/RR/ESWL
• Patient changing area and locker
15. Cleaning
and
Disinfecting
Between
Patient Use
Procedure Rooms & Recovery Room
Patient Equipment and Medical Equipment:
• Anesthesia cart and equipment (IV poles and pumps)
• Anesthesia machine
• Patient monitors
• Patient cart
• Procedure table
• Positioning devices
• Reusable table straps
• Patient transfer devices
• Stretchers/Tables
• Other equipment: e.g.
Suction regulators
Imaging monitors
Lead aprons
Laser goggles
Touch surfaces (phones, doorknobs, light switches)
• Floors and wall is soiled with splash or spray
16. COVID -19 TESTING AND QUARANTINE
ALL UNVACCINATED PATIENTS AS PER NJDOH REGS MUST HAVE:
• COVID-19 TEST before the procedure
Any specimen collection method (e.g., swab or saliva or antigen) is acceptable.
The test performed by the laboratory must be a nucleic acid amplification test (PCR) and be
either approved by the (FDA), authorized by the FDA through an Emergency Use Authorization,
or approved by the New Jersey Clinical Laboratory Improvement Services as permitted by the
FDA.
• Only patients with a negative result can be treated at the Center.
• Patients without a current test will not be treated at the Center.
17. COVID-19 TESTS
• Only SWAB or SALIVA or ANTIGEN Tests are allowed:
SARS-CoV-2 RNA COVID-19
SARS-CoV-2 RT-PCR
SARS-CoV-2 NAA
SARS-CoV-2 NAA QL
SARS-CoV-2 RNA
SARS-CoV-2 Antigen
• NO ANTIBODY TESTS ARE ALLOWED
SARS-CoV-2AB (ANTIBODY)
18. COVID-19 TESTS DEFINED
• Antigen test is a lateral flow immunochromatographic assay intended for the
qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in
nasopharyngeal or anterior nasal swab specimens.
Referred to as a Rapid Test because test results are determined within 10
minutes
Positive or Negative result
Point of Care Test
• Waived Test performed at The Stone Center
Nurses are trained and Competency performed
Quality Control done as indicated
Antigen Tests performed at The Stone Center are reported to the NJDOH
Communicable Disease Reporting and Surveillance System (CDRSS)
19. SCREENING OF PATIENTS
• Pre procedure call and Simple Admit have COVID-19 Screening
• In addition, all patients/visitors will be screened at door prior to
entering (COVID-19 Screening Tool)
• All patients/visitors entering TSC will have a temperature check:
Patients with a temp of 100◦F or greater will be cancelled. Visitors
with a temp > 100◦F will not be allowed entry.
• All patients/visitors must wear a mask before entering TSC. This will
be provided by TSC.
• Visitors (family) will not be allowed in TSC except for minors and for
patients who require assistance, legal guardians, special request, etc.
20. Screening of
Staff
Staff are required to self-screen DAILY for:
ALL staff have signed
an ATTESTATION to
do this symptom
screen before work
21. COVID-19 VACCINATION REQUIREMENTS: PATIENTS
Following NJDOH Executive Directive 20-016
Patients are exempt from COVID-19 testing and self-quarantine if the patient:
• Provides proof of full COVID-19 vaccination -2 weeks after their second dose
in a 2-dose series or 2 weeks after a single-dose vaccine.
J&J, Pfizer or Moderna Vaccine
Or one of the WHO approved vaccines (Sinovac, AstraZeneca, Covishield, Sinopharm)
Copy of the vaccination card or NJ vaccination docket, etc. must be presented to be
included on the patient’s Medical Record.
• Has tested positive for SARs-COV-2 within the last 90 days and completed the
appropriate isolation and is currently asymptomatic
• Patients who are not fully vaccinated will have SARS-CoV-2 Antigen Test
performed at The Stone Center
• Vaccine questions and instructions included in Simple Admit and in
Pre Procedure Call
22. COVID-19 VACCINATION REQUIREMENTS: STAFF
Following NJ Executive ORDERS 252 & 290
Staff should be full vaccinated which includes a booster by April 11, 2022
• Provides proof of full COVID-19 vaccination -2 weeks after their second dose
in a 2-dose series or 2 weeks after a single-dose vaccine and 3rd Booster dose.
J&J, Pfizer or Moderna Vaccine
Copy of the vaccination card or NJ vaccination docket, NJ Immunization Record must
be presented to be included for Personnel Record.
• Has tested positive for SARs-COV-2 within the last 90 days and completed the
appropriate isolation and is currently asymptomatic
• Staff who are not fully vaccinated will undergo screening testing at minimum
one to two times each week and submit proof of a COVID-19 test
Either a COVID-19 PCR or Antigen Test
23. Universal Masking
• Everyone in TSC MUST wear a mask at ALL times.
• Facemasks are provided by TSC for patients and visitors.
• Clinical staff must wear a surgical mask provided by TSC.
• Patients and visitors will not be allowed in the building without a
mask.
• Patient will be asked to wear a mask when coming to TSC and then
given a surgical mask upon entry to TSC.
24. Social Distancing
• Limit number of chairs in waiting room
• Limit chairs in lounge
• Staff will follow social distancing throughout their
workday in the Center where applicable
(i.e. workstations, lounge).
Break times and lunches will be staggered
• Scheduling of procedures will be coordinated to
promote social distancing
25. HAND WASHING
• Follow CDC guidelines for Hand
Washing
• Wash hands:
Arrival to work
When visibly soiled
Before eating
After using rest room
After exposure t to C-diff
If soiled with blood/drainage, etc.
• Can use hand sanitizer when
hands are not visibly soiled.
• Gloves
26. HAND SANITIZER
Can use hand sanitizer when
hands are not visibly soiled:
Before direct contact with patient
After contact with patient’s intact
skin( taking pulse, BP, lifting, etc.)
After removing gloves
Using hand sanitizer done the
same way as washing hands
27.
28. RESPIRATORY
PROTECTION
PROGRAM
• All staff must get fit tested
to wear the N-95/K-95 in
times of non Emergency
as per OSHA regs
oCertified Fit Tester will
perform evaluation on staff
who need to wear N-95/K-
95 masks
29. MANAGEMENT OF SUPPLIES
• Monitor PPE use for optimizing PPE in preparation of new
wave/surge of COVID-19 in NJ
Daily inventory of PPE(Burn Rate Calculator)
Daily PPE handout to prevent theft
Seven (7) day minimum supply of PPE on hand
Maintain Allocations
• Monitor other supplies – cleaning wipes, meds, etc.
• Monitor COVID-19 Testing
Reagent, swabs
Testing time
SURGES IN OTHER PARTS OF THE US AFFECT OUR SUPPLIES
31. AFTER EXPOSURE TO COVID-19
• MINIMAL RISK if wearing
proper PPE
• Staff will self monitor for
symptoms before work.
• Any staff with
community/personal exposure
need to let TSC know for
guidance to either monitor or
quarantine.
• TSC follows CDC & NJDOH
guidelines for COVID
healthcare exposure.
32. COVID-19 EXPOSURE/INFECTION
EXPOSURE IS
• Person was symptomatic or became positive within 48 hours of your contact
• Contact with person for >15 minutes in 24-hour period (15 minute total could be three, 5 minute exposures in 24
hours )
• And <6 ft away from the person
• No masks on
• Negative COVID-19 Test – if tested
INFECTION IS
• Have symptoms of COVID-19 (i.e., fever or chills, cough, shortness of breath, runny nose, congestion, headache,
fatigue, muscle & body aches, sore throat, nausea & vomiting, diarrhea, etc.,)
• Positive COVID -19 Test (Antigen, Rapid PCR, PCR)